BindingDB Entry 50033849: Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).
收藏Mendeley Data2024-03-27 更新2024-06-27 收录
下载链接：
https://www.bindingdb.org/entry/50033849
下载链接
链接失效反馈官方服务：
资源简介：
Small molecule binding data for protein ALK tyrosine kinase receptor, AXL receptor tyrosine kinase, Hepatocyte growth factor receptor, Insulin receptor, Macrophage-stimulating protein receptor, Neurotrophic tyrosine kinase receptor, Neurotrophic tyrosine kinase receptor type 2, Platelet-derived growth factor receptor beta, SRC, Tyrosine-protein kinase ABL, Tyrosine-protein kinase ABL1, Tyrosine-protein kinase TIE-2, Vascular endothelial growth factor receptor 2, and Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2), Uniprot P00519, P00520, P04629, P06213, P06239, P08581, P09619, P30530, P35968, Q02763, Q02858, Q16620, Q62190, and Q9UM73
创建时间：
2023-06-28
